Steurer W, Bonatti H, Obrist P, Spechtenhauser B, Ladurner R, Mark W, Gardetto A, Margreiter R, Königsrainer A
Department of Transplant Surgery, Innsbruck University Hospital, Austria.
Transpl Int. 2000;13 Suppl 1:S195-8. doi: 10.1007/s001470050324.
Although the introduction of FK506 and MMF has markedly improved patient and graft outcome after pancreas transplantation, this procedure is still associated with a high surgical complication rate. The aim of the following study was to retrospectively analyze a series of 40 consecutive pancreas transplants with enteric drainage with regard to intraabdominal infection (IAI). Between March 1997 and December 1998 a total of 40 whole pancreas transplants were performed. Prophylactic immunosuppression consisted of an intraoperative single shot ATG (Thymoglobulin), FK506, MMF, and prednisone. The mean observation period was 14.6 (5-26) months. Overall incidence of IAI was 27.5% (n = 11) leading to pancreatectomy in 5 patients (12.5%). In the remaining 6 patients the graft could be rescued by necrosectomy and radical drainage of the abscess (5 patients) or percutaneous drainage (1 patient). Pancreatectomy or local infection did not alter kidney graft function in the 11 patients with simultaneous pancreas kidney transplantation. In 10 patients no evidence for leakage at the site of enteric anastomosis was present, one duodenal leak occurred due to ischemia. IAI in the early postoperative period was the predominat risk factor for graft loss. An early and invasive diagnostic approach is recommended to maximize the chance of graft rescue.
尽管FK506和霉酚酸酯(MMF)的应用显著改善了胰腺移植术后患者和移植物的预后,但该手术仍伴有较高的手术并发症发生率。以下研究的目的是回顾性分析一系列连续40例采用肠内引流术的胰腺移植患者的腹腔内感染(IAI)情况。1997年3月至1998年12月期间,共进行了40例全胰腺移植手术。预防性免疫抑制包括术中单次注射抗胸腺细胞球蛋白(ATG,即Thymoglobulin)、FK506、MMF和泼尼松。平均观察期为14.6(5 - 26)个月。IAI的总体发生率为27.5%(n = 11),其中5例患者(12.5%)因IAI导致胰腺切除术。在其余6例患者中,通过坏死组织切除术和脓肿的根治性引流(5例)或经皮引流(1例)挽救了移植物。在11例同时进行胰腺 - 肾脏移植的患者中,胰腺切除术或局部感染并未改变肾移植功能。10例患者肠吻合口处无渗漏迹象,1例因缺血发生十二指肠渗漏。术后早期的IAI是移植物丢失的主要危险因素。建议采用早期且积极的诊断方法以最大程度提高挽救移植物的机会。